Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2013 Filed Jan 2, 2014 19:10 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 174 | $49.19 | $8,559.06 |
DisclosureSEC source: 0000059478-14-000002 · wf-form4_138868979972722.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,018 Read SEC document |
| December 31, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 17 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · J&S Lechleiter Grandchild Trust FBO John Richard Lechleiter Disclosed balance after: 550 F4 · ownership.nature: Irrevocable trust for the benefit of reporting person's grandchild. Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 31, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 16 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · J&S Lechleiter Grandchild Trust FBO John Richard Lechleiter Disclosed balance after: 275 F4 · ownership.nature: Irrevocable trust for the benefit of reporting person's grandchild. Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 31, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 15 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · J&S Lechleiter Grandchild Trust FBO Lannan Jeanne Lechleiter Disclosed balance after: 550 F4 · ownership.nature: Irrevocable trust for the benefit of reporting person's grandchild. Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 31, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 14 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · J&S Lechleiter Grandchild Trust FBO Lannan Jeanne Lechleiter Disclosed balance after: 275 F4 · ownership.nature: Irrevocable trust for the benefit of reporting person's grandchild. Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 31, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 11 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 50,516 F1 · ownership.nature: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 31, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 8 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,263 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:32 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 947 | $51.03 | $48,325.41 |
DisclosureSEC source: 0000059478-13-000100 · wf-form4_138610271248147.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:32 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000101 · wf-form4_138610273086624.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,327 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:32 UTC |
BISCHOFF WINFRIED F W SIRDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000102 · wf-form4_138610274938112.xml · nonDerivative · entry 1 BISCHOFF WINFRIED F W SIR · CIK 0001196150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,444 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:32 UTC |
PRENDERGAST FRANKLYN GDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000103 · wf-form4_138610276737052.xml · nonDerivative · entry 1 PRENDERGAST FRANKLYN G · CIK 0001233256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,757 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:33 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000104 · wf-form4_138610278505511.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,114 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:33 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000105 · wf-form4_138610280706423.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,280 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:33 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000106 · wf-form4_138610282519177.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,689 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:34 UTC |
HORN KAREN NDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000107 · wf-form4_138610284352852.xml · nonDerivative · entry 1 HORN KAREN N · CIK 0001136550 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,204 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:34 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000108 · wf-form4_138610286187394.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,041 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:34 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 474 | $51.03 | $24,188.22 |
DisclosureSEC source: 0000059478-13-000109 · wf-form4_138610287953592.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,589 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:35 UTC |
OBERHELMAN DOUGLAS RDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000110 · wf-form4_138610290276430.xml · nonDerivative · entry 1 OBERHELMAN DOUGLAS R · CIK 0001171770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,861 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:35 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000111 · wf-form4_138610292420446.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,010 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:35 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000112 · wf-form4_138610294373811.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,583 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:36 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 3,009 | $51.03 | $153,549.27 |
DisclosureSEC source: 0000059478-13-000113 · wf-form4_138610296149905.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,658 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:36 UTC |
GILMAN ALFRED GDirector
|
GrantCommon Stock | 2,841 | $51.03 | $144,976.23 |
DisclosureSEC source: 0000059478-13-000114 · wf-form4_138610297949749.xml · nonDerivative · entry 1 GILMAN ALFRED G · CIK 0001225473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,287 Read SEC document |
| November 26, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 6,757 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,813 Read SEC document |
| November 04, 2013 Filed Nov 5, 2013 21:00 UTC |
Mahony SusanSenior VP, Human Resources
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,056 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000059478-13-000062 · wf-form4_138368520909360.xml · derivative · entry 6 Mahony Susan · CIK 0001463321 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,056 shares Expires 2013-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2013 Filed Nov 5, 2013 21:00 UTC |
Mahony SusanSenior VP, Human Resources
|
Tax withholdingCommon Stock | 1,906 | $50.38 | $96,024.28 |
DisclosureSEC source: 0000059478-13-000062 · wf-form4_138368520909360.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,030 Read SEC document |
| November 04, 2013 Filed Nov 5, 2013 21:00 UTC |
Mahony SusanSenior VP, Human Resources
|
Exercise / conversionCommon Stock | 4,056 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-13-000062 · wf-form4_138368520909360.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2013 Filed Nov 1, 2013 17:51 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 173 | $49.65 | $8,589.45 |
DisclosureSEC source: 0000059478-13-000060 · wf-form4_138332830559840.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,649 Read SEC document |
| October 21, 2013 Filed Jan 31, 2014 15:47 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000046 · wf-form5_139118322088549.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,828 Read SEC document |
| September 30, 2013 Filed Sep 30, 2013 14:55 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 160 | $53.64 | $8,582.40 |
DisclosureSEC source: 0001209191-13-046056 · doc4.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,476 Read SEC document |
| September 11, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 6,243 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 6 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,570 Read SEC document |
| August 30, 2013 Filed Aug 30, 2013 18:13 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 163 | $52.79 | $8,604.77 |
DisclosureSEC source: 0001209191-13-042480 · doc4.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,152 Read SEC document |
| August 15, 2013 Filed Aug 16, 2013 15:18 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $53.79 | $268,950.00 |
DisclosureSEC source: 0001209191-13-041072 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,177 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013. Read SEC document |
| August 09, 2013 Filed Jan 31, 2014 15:47 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 3,721 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000048 · wf-form5_139118325651089.xml · nonDerivative · entry 3 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 270,129 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| July 31, 2013 Filed Aug 1, 2013 14:37 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 167 | $51.54 | $8,607.18 |
DisclosureSEC source: 0001209191-13-038578 · doc4.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,989 Read SEC document |
| July 29, 2013 Filed Jul 30, 2013 19:31 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
SaleCommon Stock | 7,500 | $53.74 | $403,050.00 |
DisclosureSEC source: 0001209191-13-038288 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,302 Read SEC document |
| July 15, 2013 Filed Jul 15, 2013 20:23 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $51.43 | $257,150.00 |
DisclosureSEC source: 0001209191-13-036637 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,177 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013. Read SEC document |
| June 28, 2013 Filed Jul 1, 2013 17:50 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 164 | $52.36 | $8,587.04 |
DisclosureSEC source: 0001209191-13-034228 · doc4.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,822 Read SEC document |
| June 17, 2013 Filed Jun 18, 2013 14:34 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $52.45 | $262,250.00 |
DisclosureSEC source: 0001209191-13-032601 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,177 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013. Read SEC document |
| June 13, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 976 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 10 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 51,066 F1 · ownership.nature: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| June 13, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 976 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 5 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,813 Read SEC document |
| May 31, 2013 Filed Jun 3, 2013 16:27 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 156 | $52.00 | $8,112.00 |
DisclosureSEC source: 0001209191-13-030058 · doc4.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,496 Read SEC document |
| May 31, 2013 Filed Jan 31, 2014 15:47 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000047 · wf-form5_139118323771384.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Read SEC document |
| May 29, 2013 Filed Jan 31, 2014 15:47 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 92 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000046 · wf-form5_139118322088549.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,849 Read SEC document |
| May 15, 2013 Filed May 16, 2013 20:06 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $56.15 | $280,750.00 |
DisclosureSEC source: 0001209191-13-026800 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,177 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013. Read SEC document |
| May 14, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 9,969 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 4 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,789 Read SEC document |
| May 10, 2013 Filed May 13, 2013 19:37 UTC |
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health
|
SaleCommon Stock | 10,000 | $54.49 | $544,900.00 |
DisclosureSEC source: 0001209191-13-025785 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,750 F1 · price: This transaction was executed in multiple trades at prices ranging from $54.49 to $54.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 10, 2013 Filed Jan 31, 2014 15:46 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000045 · wf-form5_139118320073486.xml · nonDerivative · entry 3 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,758 Read SEC document |
| May 01, 2013 Filed May 1, 2013 19:44 UTC |
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-023300 · doc4.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2013-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2013 Filed May 1, 2013 19:44 UTC |
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health
|
Tax withholdingCommon Stock | 4,635 | $55.38 | $256,686.30 |
DisclosureSEC source: 0001209191-13-023300 · doc4.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,750 Read SEC document |
| May 01, 2013 Filed May 1, 2013 19:44 UTC |
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health
|
Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-023300 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.